CD38 in Chronic Lymphocytic Leukemia: From Bench to Bedside?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|11|6|503-507

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.11, Iss.6, 2011-06, pp. : 503-507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple Metamorphoses of CD38 from Prognostic Marker to Disease Modifier to Therapeutic Target in Chronic Lymphocytic Leukemia

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 23, 2013-12 ,pp. : 2955-2964

Bentham Science Publishers

Access to resources Recommend Favorite

Genomic tools in acute myeloid leukemia: From the bench to the bedside

By White Brian S.   DiPersio John F.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1134-1144

Blackwell Publishing

Access to resources Recommend Favorite

Vascular NO: from bench to bedside

By Tsikas Dimitrios  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 3-3

Springer Publishing Company

Access to resources Recommend Favorite

CETUXIMAB: From Bench to Bedside

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-01 ,pp. : 80-95

Bentham Science Publishers

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig   Lamanna Nicole   Weiss Mark A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite